| Literature DB >> 32411024 |
Nicole Korman1,2, Harley Fox2, Tina Skinner3, Cassandra Dodd1, Shuichi Suetani1, Justin Chapman1,4, Stephen Parker1,2, Frances Dark1,2, Cheryl Collins3, Simon Rosenbaum5, Dan Siskind1,2.
Abstract
PURPOSE: People with severe mental illness (SMI) experience poor physical health and premature mortality, contributed significantly by modifiable lifestyle risk factors such as poor nutrition, low cardiorespiratory fitness, and physical inactivity. Lifestyle interventions can reduce cardiometabolic risk and confer a range of other positive mental and physical health benefits. We assessed the feasibility, acceptability, safety, and preliminary effectiveness of a lifestyle (combined dietary and exercise) intervention lead by senior exercise and dietetics students in a residential mental health rehabilitation setting.Entities:
Keywords: diet; exercise; lifestyle intervention; physical activity; rehabilitation; schizophrenia; severe mental illness; student placement
Year: 2020 PMID: 32411024 PMCID: PMC7198865 DOI: 10.3389/fpsyt.2020.00319
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Participant Characteristics.
| Total | Completers | Withdrawals | t(df) or z | p value | |
|---|---|---|---|---|---|
| (n= 42) | (n=32) | (n=10) | |||
| 30 (9) | 31 (10) | 29 (8) | t(40)=−0.37 | 0.715 | |
| Males: | 33 (78) | 27 (84) | 6(60) | 0.181a | |
| 1 (2) | 1 (3) | 0 (0) | |||
| High school | 27 (64) | 18 (56) | 9 (90) | 0.061a | |
| Tertiary | 16 (38) | 15 (45) | 1 (11) | ||
| Schizophrenia/schizoaffective | 39 (93) | 30 (92) | 9 (90) | ||
| Bipolar affective disorder | 1 (2) | 1 (3) | 0 (0) | ||
| Major depressive disorder | 2 (4) | 2 (6) | 0 (0) | ||
| Substance abuse disorder | 1 (2) | 0 (0) | 1 (11) | ||
| 9 (21) | 3 (9) | 6 (60) | 0.002a* | ||
| 7.5 (2.9–10.0) | 8.5 (2.1–11.5) | 4.0 (3.0–5.5) | z= −1.08 | 0.286 | |
| 2.0 (1.0–8.2) | 4.5 (1.0–9.0) | 1.0 (0.5–2.0) | z= −2.45 | 0.014* | |
| 3.8 (2.1) | 3.7 (2.0) | 3.6 (2.6) | 0.892 | ||
| Clozapine or olanzapine | 26 (62) | 20 (61) | 6 (60) | 1.00a | |
| HTN: | 2 (4.8) | 2 (6) | 0 | ||
| DM: | 0 (0) | 0 | 0 | ||
| 9 (21) | 8 (24) | 1 (11) | 0.653a | ||
| 20 (48) | 13 (41) | 7 (70) | 0.152a |
All measures are presented as mean and standard deviation unless stated otherwise.
NP, Non-parametric: median and interquartile range; n, number of participants; HTN, hypertension; DM, diabetes mellitus.
*p <0.05 = significant, aFisher’s exact test—when one or more cell has a cell count frequency of < 5.
Figure 1CONSORT diagram.
Pre- and Post-Intervention Measures.
| Baseline | Post | Mean change | t(df) or z | p value | |
|---|---|---|---|---|---|
| (n=32) | (n=32) | ||||
| 6MWT, meters: | 476.63 (83.53) | 533.47 (88.61) | 56.84 (49, 73.6) | t(31) =6.89 | <0.001*b |
| Systolic: | 121.4 (9.6) | 119.7 (8.1) | −1.2(−4.4, 1.9) | t(31)=−0.79 | 0.435 |
| Diastolic: | 79.6 (7.4) | 76.4 (7.9) | −2.9 (0.2–5.9) | t(32)=−1.93 | 0.062 |
| BMI: kg/m2 | 28.5 (6.8) | 28.7 (7.1) | 0.4 (−0.2, 1) | t(32)=1.33 | 0.192 |
| Waist: cm | 100.7 (16.1) | 98.4 (18.6) | −0.9 (−0.29, 1.2) | t(31)=−0.84 | 0.405 |
| Blood glucose: | 5.3 (0.6) | 5.1 (0.5) | −0.05 (−0.2, 0.09) | t(27)=−0.73 | 0.472 |
| TC: | 4.9 (4.4–5.8) | 5.2 (4.3–5.8) | z=0.92 | 0.360 | |
| HDL: | 1.1 (0.2) | 1.29 (0.8) | −0.21 (−0.5–0.1) | t(29)=−1.41 | 0.170 |
| LDL: | 3.0 (2.5–3.7) | 3.0 (2.4–3.8) | z=0.64 | 0.524 | |
| Trig: | 1.4 (1.0–2.1) | 1.5 (1.1–2.1) | z=0.83 | 0.404 | |
| Sedentary: h/day | 5.0 (4.0–8.0) | 4.0 (3.0–6.5) | z=−0.97 | 0.332 | |
| Mod−Vig: min/week | 75 (0–188) | 120 (45–255) | z=1.93 | 0.053 | |
| Total Ex volume: min/week | 250 (117–417) | 360 (208–548) | z=2.24 | 0.025* | |
| BPRS: | 37.7 (11.2) | 32.1 (7.4) | 4.9 (0.7–9.2) | t(26)=2.42 | p=0.023* |
| Total: | 42 (31–58) | 27 (17–38) | z=−4.2 | p= < 0.001*b | |
| Affect: | 17 (10–21) | 10 (4–14) | z=−3.01 | p=0.003* | |
| Alogia: | 2 (0–8) | 0 (0–4) | z=−2.50 | p=0.012* | |
| Functioning: | 7 (4–11) | 5 (1–6) | z=−3.17 | p=0.002*b | |
| Social: | 15 (10–18) | 12 (8–15) | z=−1.9 | p=0.062 | |
| Cognitive: | 4 (0–7) | 1 (0–3) | z=−2.18 | p=0.029* | |
| Amotivation: | 0 (0–.25) | .5 (0–.75) | z=2.66 | p=0.008* | |
| External regulation: | .5 (0–2) | .75 (0–1.87) | z=1.29 | p=0.196 | |
| Introjected Regulation: | 1 (0–2.47) | 1 (.50–2.17) | z=0.29 | p=0.769 | |
| Identified Regulation: | 3 (2.5–3.5) | 2.75 (1.62–3.12) | z=−2.0 | p=0.041* | |
| Intrinsic regulation: | 3 (2–4) | 2.5 (1.87–3.12) | z=−1.4 | p=0.146 |
All measures are presented as mean and standard deviation unless stated otherwise. *p< 0.05 (significant).
bBonferroni correction (≤0.002); CI, confidence interval, NP, non-parametric data presented as median and interquartile range; BMI, body mass index; HTN, hypertension; T2DM, type 2 diabetes mellitus; TC, total cholesterol; HDL, high density lipoprotein; LDL, low density lipoprotein; Trig, triglycerides; n, number of participants; WHR, waist hip ratio; Mod-Vig, moderate to vigorous; Ex, exercise; 6MWT, 6 Minute Walk Test; SIMPAQ, Simple Physical Activity Questionnaire; BPRS, Brief Psychiatric Rating Scale; SANS, Scale for the Assessment of Negative Symptoms.